PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist studied as a ligand probe for melanocortin receptor pharmacology. Experimental systems evaluate its interaction with MC3R and MC4R receptors and associated second-messenger signaling pathways. Laboratory investigations focus on receptor activation dynamics and neuroendocrine signaling mechanisms under controlled research conditions without implying human outcomes.
Products will arrive in a lyophilized (powder) form to maximize stability and shelf life.
$39